Editorials

• Women with breast cancer and importance of early referral to fertility preservation - Kutluk Oktay - Institute for Fertility Preservation, New York Medical College/Westchester Medical Center, Valhalla, NY, USA




• Nuclear medicine breast studies carry much higher radiation doses and risks than mammography - Ed Hendrick - Department of Radiology, University of Colorado-Denver, School of Medicine, Aurora, CO USA




• Role of partial breast irradiation compared with whole breast radiotherapy in early breast cancer - Antonis Valachis - Department of Medical Oncology, University General Hospital of Heraklion, Greece Onkologkliniken Sormland, Malarjukhuset, Eskilstuna, Sweden




• MRI and triple receptor-negative breast carcinomas - Basak E. Dogan - Departments of Radiology and Breast Imaging-Unit, The University of Texas M. D. Anderson Cancer Center , Houston, TX, USA




• Pulmonary metastasectomy can be a reasonable treatment option in patients with isolated lung metastasis - Do-Youn Oh - Department of Internal Medicine, Seoul National University Hospital, Korea




• The length of interval between breast conserving surgery and start of radiotherapy affects local recurrence - Rinaa Punglia - Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA




• Optimal management of breast cancer patients with sentinel lymph node micrometastases - Sonia Pernas - Medical Oncology Department, Institut Catal… d'Oncologia, L'Hospitalet, Barcelona, Spain




• Treatment of Occult Breast Carcinoma Presenting Axillary Metastases - Xin Wang - First Department of Breast Tumor, Tianjin Medical University Cancer Hospital and Institute; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education; Tianjin, China




• Aspirin can significantly reduce the risk of cancer spread and death for patients who have been treated for early-stage breast cancer- Michelle D. Holmes - Harvard School of Public Health, Harvard Medical School, Brigham & Women's Hospital, Boston, MA , USA




• Performing preoperative breast MRI in all women with invasive lobular carcinoma can reduce the need for re-excision- Ritse Mann - Department of Radiology, Radboud University Nijmegen, Medical Centre, Nijmegen, The Netherlands




• There is no strict indication to systematic MRI screening of the contralateral breast in women with newly diagnosed invasive breast cancer- Stefano Ciatto - Valeggio sul Mincio, Verona, Italy




• A significant number of patients show discordant quantitative expression of molecular markers between primary breast cancer and nodal metastases- Dana Faratian - Edinburgh Breakthrough Research Unit and Division of Pathology, University of Edinburgh, Edinburgh, UK




• Effect of a multimodal group exercise intervention in cancer patients undergoing chemotherapy - Lis Adamsen - Institute of Public Health, University of Copenhagen, Copenhagen, Denmark




• A history of smoking increases a woman.s risk for developing breast cancer -Ivana T. Croghan - Mayo Clinic College of Medicine, Rochester, Minnesota, USA




• Human papillomavirus and breast cancer - James Lawson - School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia




• Oligometastatic disease is potentially curable with multimodality therapy incorporating stereotactic body radiation therapy - Mike Milano - Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA




• Some elderly breast cancer patients may be spared lymph node evaluation - Anees B. Chagpar - Division of Surgical Oncology, Department of Surgery, University of Louisville, Louisville, Kentucky, USA




• Systemic inflammation may affect breast epithelial cancer - James Goedert - Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA




• Routine dissection of the internal mammary chain sentinel node is safe and assists treatment planning for both chemotherapy and radiation therapy - John Boyages - New South Wales Breast Cancer Institute, Westmead Hospital, New South Wales, Australia




• Impact of locoregional treatment on the survival of breast cancer patients with synchronous metastases - Romuald Le Scodan - Department of Radiation Oncology, Centre Renéuguenin, Saint Cloud, France




• Radiotherapy After Segmental Resection is Beneficial Even Among Women With Low Risk Breast Cancer - Kaija Holli - Departments of Oncology and Surgery, Tampere University Hospital, Tampere University Medical School, Tampere, Finland




• A novel endoscopic-assisted technique for skin-sparing mastectomy - Ken-ichi Ito - Division of Breast and Endocrine Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto; Nagano, Japan




• Skin necrosis after partial breast irradiation - Edward R. Sauter, Steven Westgate, Janice Templemire - Departments of Surgery and Radiology, Ellis Fischel Cancer Center, Columbia, MO and Department of Surgery, University of North Dakota, Grand Forks, ND, USA




• Direct MR galactography is a feasible tool to work up nipple discharge - Siegfried A. Schwab - Department of Radiology, Universita' Erlangen-Nurnberg, German




• Nonsteroidal anti-inflammatory drugs use is associated with reduced risk for breast cancer - Bahi Takkouche - Department of of Preventive Medicine, University of Santiago de Compostela, Spain




• The role of insulin-like growth factor-I (IGF-I) in human breast cancer - Adrian V. Lee - Breast Center, Baylor College of Medicine, Houston, TX , USA




• Preoperative chemotherapy is a safe procedure for patients with early breast cancer - Janine van Nes - Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands




• Removing 5 sentinel lymph nodes is enough for accurate lymph node staging in the vast majority of breast cancers - Kelly K. Hunt - Surgical Breast Section, Department of Surgical Oncology, M. D. Anderson Cancer Center, Houston, TX, USA




• MRI is probably sufficiently sensitive to rule out bone marrow involvement in patients with malignant lymphoma - Thomas Kwee - University Medical Center Utrecht, Utrecht, The Netherlands




• Annual MRI is the screening test of choice for all women over 30 with BRCA mutations - Ellen Warner - Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada




• Local ablative therapy of breast cancer - Heriberto Medina - Department of Surgery, Section of Surgical Oncology, National Institute of Medical Sciences and Nutrition “Salvador Zubiran, Mexico City, Mexico




• Contribution of ultrasound in detecting breast cancer in women with dense breasts and negative mammograms - Stefano Ciatto - CSPO - Istituto Scientifico Prevenzione Oncologica, Firenze, Italy




• Women with breast cancer who exercise are more likely to survive longer than women who are less active - Crystal N. Holick - Ingenix i3 Drug Safety, Waltham, MA, USA




• Development of hypothyroidism is common in older breast cancer survivors - Grace L. Smith - Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA




• Survival after adjuvant oophorectomy and tamoxifen in premenopausal women with operable breast cancer - Richard R. Love - Ohio State University, Columbus, OH, USA




• Effect of breast cancer surgery timing during the menstrual cycle on prognosis - Richard Sainsbury - Clinical Trials Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK




• Diagnostic performance of MR imaging in patients suspected of having breast cancer - Nicky Peters - Department of Radiology, University Medical Center Utrecht, Heidelberglaan 100, E01.132, 3584 CX Utrecht, The Netherlands




• Sarcomas of the breast - Sarcomas of the breast - Oscar Lambret Center, Lille, France; University of Lille II, Lille, France




• The effect of adjuvant chemotherapy in young patients with breast cancer in relation to hormone receptor status - Jos van der Hage - Leiden University Medical Center, Department of Surgery, Leiden, The Netherlands




• Models for predicting the presence of mutations in the BRCA1 and BRCA2 genes - Giovanni Parmigiani - The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA




• Routine use of postoperative chest wall and nodal irradiation in all T3pN0 breast cancer patients may not be required - John E. Mignano - Department of Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD, USA




• Quality of life is better in metastatic breast cancer women receiving chemotherapy than those under only supportive care - Michalis V. Karamouzis - First Department of Medical Oncology, St. Savvas Anticancer-Oncologic Hospital, Athens, Greece




• Combined influence of diet and physical activity on breast cancer survival - John Pierce - Cancer Prevention and Control Program, Moores University of California, San Diego Cancer Center, La Jolla, CA, USA




• Long-term follow-up of early-stage breast cancer patients treated by breast-conserving surgery should be based on mammography - David Montgomery - University Department of Surgery, Glasgow Royal Infirmary, Glasgow, Scotland, UK




• The value of fiberoptic ductoscopy combined with cytology testing as a diagnostic procedure in women with nipple discharge - Guangyu Liu - Department of Breast Surgery, Cancer Hospital/Cancer Institute, Fudan University, Shanghai, People's Republic of China




• Screening mammography in women 40 to 49 years of age - Amir Qaseem, Department of Clinical Programs and Quality of Care, American College of Physicians, Philadelphia, PA, USA




• Risk of Cardiovascular Disease in Survivors of Breast Cancer - Maartje J. Hooning, Department of Medical Oncology, Erasmus MC, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands




• Effect on disease-free survival of concurrent vs. sequential chemotherapy and radiotherapy after breast-conserving surgery for stage I-II breast cancer - Alain Toledano, Department of Radiation Oncology, Henry Kaplan, Hopital Bretonneau, Tours, France




• Men diagnosed with breast cancer have a higher risk of suffering a second cancer - Sacha Satram-Hoang, Epidemiology Division, School of Medicine, University of California, Irvine, CA, USA




• Prognostic significance of triple negative breast cancers with respect to locoregional relapse and distant metastasis in conservatively managed patients - Bruce G. Haffty, Department of Radiation Oncology, UMDNJ-Robert Wood Johnson Medical School, Cancer Institute of New Jersey, New Brunswick, NJ, USA




• Hormone replacement therapy and breast cancer risk - Lothar Heinemann, Centre for Epidemiology & Health Research Berlin, Berlin, Germany




• High-dose chemotherapy and stem-cell rescue for women with metastatic breast cancer - Sobha Kurian - West Virginia University, Morgantown, West Virginia, USA




• Risk factors of breast cancer related lymphedema - Atilla Soran - Professor of Surgery, Director of International Breast Fellowship Program, Magee-Womens Hospital of UPMC, Pittsburgh, PA, USA




• Core needle biopsy and subsequent excisional biopsy in patients with breast high-risk lesions - Julie Margenthaler - Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA




• Sentinel lymph node biopsy should be considered in all patients with a diagnosis of ductal carcinoma in situ with microinvasion - Giorgio Zavagno - Clinica Chirurgica II, University of Padova, Padova, Italy




• Role of FDG-PET/CT in the assessment of suspected recurrent breast cancer - Simona Ben-Haim - Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel




• Clinical benefit of radiation therapy for older women with DCIS - Ben Smith - Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA




• Postmastectomy radiation therapy is associated with improved survival for older women with high-risk breast carcinoma - Ben Smith - Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA




• “Below threshold” familial breast cancer risk information can be conveyed by letter, but attention should be given to further support for these women - Michael Steel - Tayside Breast Cancer Family Clinic, Ninewells Hospital and Medical School, Dundee, UK




• Gene expression profiling can identify individual patients at increased risk of developing a local recurrence after breast-conserving therapy - Dimitry Nuyten - Division of of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands




• Prior oral contraceptive use is associated with premenopausal breast cancer - Chris Kahlenborn - Department of Internal Medicine, Altoona Hospital, Altoona, PA, USA




• Perineural invasion in patients with invasive breast carcinoma - Nuvit Duraker - Fifth Department of Surgery, SSK Okmeydani Training Hospital, Istanbul, Turkey




• Positive impact of a patient information booklet about BRCA genetic testing - Julien Mancini and Claire Julian-Reynier - INSERM UMR379, Epidemiology and Social Sciences Unit, Paoli-Calmettes Institute, Marseille, France




• Structured, group-based cognitive behavior stress management may ameliorate cancer-related anxiety during active medical treatment for breast carcinoma - Mike Antoni - Department of Psychology, University of Miami, Coral Gables, FL, USA




• Utility of FDG PET for evaluating treatment response in breast cancer - Rod Hicks - Centre for Molecular Imaging, The Peter MacCallum Cancer Centre, Melbourne, Australia




• Breast conservation may be offered to women with prior augmentation mammoplasty when selected appropriately - Kristin L Brill - Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA




• Nanoparticles for detection of breast cancer metastases - Carola Leuschner - Pennington Biomedical Research Center, LSU System, Baton Rouge, LA, USA




• Multicentric Breast Cancer and Sentinel Node Biopsy - Michael Knauer - Department of General and Thoracic Surgery, General Hospital, Feldkirch, Austria




• Rates of suicides among women who received breast implants - Paul J. Villeneuve, Yang Mao

  
  

• A Single-Institution Experience with Inflammatory Breast Cancer - David R. Farley - Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn, USA

  
  

• Radiotherapy schedules in women with invasive breast cancer can be greatly simplified - John Yarnold

  
  

• High-dose chemotherapy and stem-cell rescue for women with metastatic breast cancer - Sobha Kurian

  
  

• Risk factors of breast cancer related lymphedema - Atilla Soran

  
  

• Core needle biopsy and subsequent excisional biopsy in patients with breast high-risk lesions - Julie Margenthaler

  
  

• Sentinel lymph node biopsy should be considered in all patients with a diagnosis of ductal carcinoma in situ with microinvasion - Giorgio Zavagno

  
  

• Role of FDG-PET/CT in the assessment of suspected recurrent breast cancer - Simona Ben-Haim

  
  

• Clinical benefit of radiation therapy for older women with DCIS - Ben Smith

  
  

• Postmastectomy radiation therapy is associated with improved survival for older women with high-risk breast carcinoma - Ben Smith

  
  

• “Below threshold” familial breast cancer risk information can be conveyed by letter, but attention should be given to further support for these women - Michael Steel

  
  

• Gene expression profiling can identify individual patients at increased risk of developing a local recurrence after breast-conserving therapy - Dimitry Nuyten

  
  

• Prior oral contraceptive use is associated with premenopausal breast cancer - Chris Kahlenborn

  
  

• Perineural invasion in patients with invasive breast carcinoma - Nuvit Duraker

  
  

• Positive impact of a patient information booklet about BRCA genetic testing - Julien Mancini and Claire Julian-Reynier

  
  

• Structured, group-based cognitive behavior stress management may ameliorate cancer-related anxiety during active medical treatment for breast carcinoma - Mike Antoni

  
  

• Predictors of Invasion in Patients With Core-Needle Biopsy-Diagnosed Ductal Carcinoma in Situ - Erika Resetkova

  
  

• Predictors of lymph node involvement in women with asymptomatic invasive breast cancers detected through screening mammography - David Roder

  
  

• Mammary ductoscopy is useful as a direct and accurate method of characterizing intraductal lesions - Masujiro Makita

  
  

• MR guided Focused Ultrasound Surgery for the Palliation of Pain Caused by Bone Metastases - Doron Kopelman

  
  

• Aerobic exercise prevents anemia during treatment of breast cancer - Jacqueline S. Drouin

  
  

• Prophylactic mastectomy and sentinel lymph node surgery - Judy C. Boughey

  
  

• Relationship of regional cerebral blood flow and metabolism with cognitive function and past exposure to chemotherapy for breast cancer - Dan Silverman

  
  

• Utility of FDG PET for evaluating treatment response in breast cancer - Rod Hicks

  
  

• Breast conservation may be offered to women with prior augmentation mammoplasty when selected appropriately - Kristin L Brill

  
  

• Nanoparticles for detection of breast cancer metastases - Carola Leuschner

  
  

• Multicentric Breast Cancer and Sentinel Node Biopsy - Michael Knauer

  
  

• Rates of suicides among women who received breast implants - Paul J. Villeneuve, Yang Mao

  
  

• A Single-Institution Experience with Inflammatory Breast Cancer - David R. Farley

  
  

• Radiotherapy omission after breast-conserving surgery in elderly women with breast cancer - Pauline Truong

  
  

• Breast cancer treatment in octogenarians - Haim Gutman

  
  

• Using an instruction video or palpation aid did not improve the effectiveness of breast examination in detecting tumors - Karsten Munstedt

  
  

• Screening younger women with a family history of breast carcinoma leads to improved survival - Gareth Evans

  
  

• Hypofractionated radiotherapy and hormonal therapy without surgery for breast carcinoma in elderly patients - Adel Courdi

  
  

• Conservative management of non-bloody nipple discharge - Mary Dillon

  
  

• Proliferation: the most prominent predictor of clinical outcome in breast cancer - Christos Sotiriou

  
  

• Sentinel lymph nodes in breast cancer can be falsely positive - Ira J Bleiweiss

  
  

• Association between type 2 diabetes mellitus and adverse characteristics of breast cancer at presentation - Ido Wolf

  
  

• Boost radiotherapy in addition to surgery for breast-conserving treatment for DCIS - Guenther Gruber

  
  

• Radiotherapy schedules in women with invasive breast cancer can be greatly simplified - John Yarnold

  
  

• Estradiol and its metabolites are genotoxic in human breast epithelial cells - Jose Russo

  
  

• Genetic factors may play a large role in explaining variation in the mammographic areas of both dense and nondense tissue in the breast - Jennifer Stone

  
  

• Complete Excision of Primary Breast Tumor in women diagnosed with a breast cancer already metastasized - Elisabetta Rapiti

  
  

• Breast cancer in elderly patients - Ella Evron

  
  

• Is Wide Excision Alone Sufficient for Ductal Carcinoma in Situ (DCIS)? - Julia Wong

  
  

• The importance of radiation therapy for older women with early breast cancer - Benjamin D. Smith

  
  

• Breast cancer risk in female radiologic technologists - Michele Doody

  
  

• Metaplastic breast carcinoma - J. David Beatty

  
  

• Overexpression of HER-2/neu in primary breast cancer would predict metastases to the sentinel lymph nodes - David Nathanson

  
  

• All stellate lesions seen on breast screening mammograms should be excised - Tarannum Fasih

  
  

• Validation of the 76-gene prognostic signature in breast cancer - John A. Foekens

  
  

• Circulating sex steroid hormone levels and risk of breast cancer - A. Heather Eliassen

  
  

• Children's perceptions of their mother's breast cancer - Gillian Forrest

  
  

• Intrathecal trastuzumab for the treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer - Joachim Stemmler

  
  

• Hormone Replacement Therapy and the Accuracy of Screening Mammography - Maria del Mar Vernet Tomàs

  
  

• The role of the general practitioner in follow-up of patients with cancer - Tor Anvik

  
  

• The use of high-dose alkylating agents is a promising approach for breast cancer that does not respond to neoadjuvant therapy - Naoto T. Ueno

  
  

• The role of two markers, maspin and mammaglobin B, for the non invasive diagnosis of breast cancer - Emanuela Flamini

  
  

• Parasternal sentinel node biopsy in breast cancer - Marjut Leidenius

  
  

• Ipsilateral breast tumor recurrence and local-regional recurrence after neoadjuvant chemotherapy and breast-conserving therapy - Sushil Beriwal

  
  

• Reduction mammaplasty is a consistent technique for reconstruction following breast-conserving surgery - Alexandre Mendonça Munhozz

  
  

• Soy intake and breast cancer risk - Bruce J. Trock

  
  

• A computer-mediated support group for women with breast carcinoma affects breast cancer-related concerns, emotional well-being and self-reported physical well-being - Bret Shaw

  
  

• The treatment of malignant pleural effusion via video-assisted thoracoscopy ( VATS) in breast carcinoma - Roberto Gasparri

  
  

• MR-guided vacuum assisted (VAB) biopsy of the breast - Claudia Perlet

  
  

• Psychosocial outcomes after prophylactic removal of the contralateral breast in women with unilateral breast cancer - Ann M. Geiger

  
  

• Trastuzumab and chemotherapy in advanced breast cancer after the failure of one earlier combination - Rupert Bartsch

  
  

• A new model for the genesis of human cancer - Peter Grandics

  
  

• Surgical prophylaxis in women at increased genetic risk for both ovarian and breast cancer - Yoland Antill

  
  

• Melatonin could exert antitumoral effects on hormone-dependent mammary tumors - Emilio J. Sanchez-Barcello'

  
  

• Risk of compromised margins following breast conservation for invasive lobular carcinoma - Mary Dillon

  
  

• Should Mammography be offered as a screening tool to women aged 40-49? - Sophie Helme, Kefah Mokbel

  
  

• Impact of familial risk factors on management and survival of women with early-onset breast cancer - Helena M Verkooijen, Christine Bouchardy

  
  

• Mouse mammary tumour virus (MMTV) antibodies in women with breast cancer - James J. Goedert

  
  

• Ovarian function protection during adjuvant chemotherapy.in premenopausal women with early breast carcinoma - Francesco Recchia

  
  

• Effects of specialisation on the management of screen-detected breast cancers - Prue Allgood

  
  

• Use of the antidepressant sertraline for management of hot flashes - Gretchen G. Kimmick

  
  

• Key factors identified to allow cancer patients to die at home - Barbara Gomes, Irene Higginson

  
  

• Intensity modulated radiation therapy (IMRT) for breast cancer decreases acute skin toxicity - Gary M. Freedman

  
  

• Implant breast reconstruction after radiation therapy for breast cancer - Jeffrey Ascherman

  
  

• Post-pregnancy Events Promote Breast Cancer Metastasis - Pepper Schedin

  
  

• Ocular toxicity after adjuvant chemo-endocrine treatment for early breast cancer - Lorenzo Gianni

  
  

• The experiences of men with breast cancer - Rachel Iredale

  
  

• Breast implants for cosmetic purposes and long-term risk of developing cancer - Lin Xie

  
  

• Reduction in the risk of breast cancer with the use of selective COX-2 inhibitors - Randall E. Harris

  
  

• Favourable outcome of screen-detected breast cancers - Laura Cortesi

  
  

• MIB-1 proliferation index and the risk of lymph node metastasis in breast cancer - Daniele Marrelli

  
  

• The low use of breast reconstruction after mastectomy - Amy Alderman

  
  

• Differences in the management of older women with breast cancer are associated with poorer survival - Sonja Eaker

  
  

• Effects of soy isoflavones on breast cancer risk - Charles E. Wood

  
  

• Minute quantities of estrogen act as an apoptotic trigger in breast cancer cells resistant to estrogen deprivation - V. Craig Jordan

  
  

• The use of trastuzumab in the treatment of early breast cancer: results from the HERA trial - Daniela D. Rosa, Lissandra Dal Lago, Chantal Bernard and Martine J. Piccart

  
  

• Sex hormone levels and breast cancer risk - Mary S. Beattie

  
  

• Tumor gene expression profiles and risk of distant recurrence in breast cancer patients - Melody A. Cobleigh

  
  

• Additive interactions between bisphosphonates and ER antagonists in estrogen receptor-positive breast cancer cell lines - Fabrice JournéJean-Jacques Body

  
  

• ‘Real-life’ experience of fulvestrant from an Austrian centre involved in a Compassionate Use Programme - Guenther G. Steger

  
  

• Chemioterapia adiuvante dose-dense nel trattamento del carcinoma della mammella - Marco Venturini

  
  

• Targeted ultrasound for detection and biopsy of breast MRI-detected lesions - LeAnn Beran

  
  

• Second cancer after female breast cancer - Lene Mellemkjæ

  
  

• MRI should be considered an integral part of any surveillance program for women with a familial risk for breast cancer - Christiane Kuhl

  
  

• An increased risk of breast cancer in night workers may in part be mediated by the melatonin pathway - Eva Schernhammer

  
  

• Frequent use of Nonsteroidal Anti-Inflammatory Drugs and occurrence of breast cancer - Elham Rahme

  
  

• Polymorphisms in the estrogen receptor alpha gene, mammographic density and breast cancer risk - Fräel J.B. van Duijnhoven

  
  

• Effects of chemotherapy on cognitive function - Catherine Jansen

  
  

• Concurrent administration of CMF chemotherapy and radiotherapy after breast-conserving surgery for mammary carcinomas - Giorgio Arcangeli

  
  

• Long-term prognosis of patients with isolated local recurrence following conservative surgery and radiotherapy for early breast cancer - Adri C Voogd

  
  

• Adjuvant radiotherapy for breast cancer and cardiac morbidity - Sharon Giordano

  
  

• Axillary Lymph Node Dissection in Breast Cancer Patients with Sentinel Lymph Node Micrometastases - Marco Gipponi

  
  

• HER-2 overexpression as a predictor of outcome in breast cancer patients - Mariantonietta Colozza

  
  

• A HER2/neu vaccine to prevent recurrence in high-risk breast cancer patients - George E. Peoples

  
  

• Breast cancer treatment and sexual function - Justine J. Speer

  
  

• Use of hormone replacement therapy following bilateral risk-reducing oophorectomy in women with BRCA1/2 mutations - Timothy R. Rebbeck

  
  

• Tamoxifen and chemopreventive treatment for breast cancer risk reduction - Bernard Fisher

  
  

• In-situ male breast carcinoma - William F Anderson

  
  

• Gene expression profiling spares early breast cancer patients from adjuvant therapy - Yudi Pawitan

  
  

• Isolated recurrences of breast carcinoma and adjuvant systemic therapy after completion of local therapy - Edgardo Rivera

  
  

• Decision-making, satisfaction, psychological and social function after contralateral prophylactic mastectomy - Marlene H. Frost

  
  

• Breast cancer patients and timing of adjuvant chemotherapy - Soeren Cold

  
  

• The MammoSite balloon brachytherapy device in women undergoing breast conserving surgery - Andrew DiFronzo

  
  

• Spinal stereotactic radiosurgery for breast carcinoma metastases - Peter Gerszten

  
  

• Human Papilloma Virus and breast cancer - James Lawson

  
  

• Axillary recurrence after sentinel node dissection in early stage breast cancer - Karen K. Swenson

  
  

• Digital and film mammography as a means of screening - Etta D. Pisano

  
  

• Surgery and angiogenesis in breast cancer - Michael Retsky

  
  

• Mammaglobin as a serum biomarker for breast cancer - Jonine L. Bernstein

  
  

• Quality of Life determinants in breast cancer patients undergoing treatment with curative intent - Manoj Pandey

  
  

• TNM classification and breast cancer with noninflammatory skin involvement: T4 category should be revised generally - Uwe Guth

  
  

• Detection of circulating epithelial cells in peripheral blood and therapy monitoring - Katharina Pachmann

  
  

• Breast cancer screening, as performed in the real community setting, did not reduce breast cancer deaths as much as expected - Lisa M. Reisch

  
  

• Identification of patients at high risk for hereditary breast/ovarian cancer syndrome in a mammography population - Kevin S. Hughes, Francisco J Dominguez

  
  

• Hereditary breast cancer growth rates and screening-interval - Madeleine MA Tilanus-Linthorst

  
  

• Tamoxifen For Breast Cancer Chemoprophylaxis: factors influencing the decision - Rebecca Taylor

  
  

• Gene-expression patterns in peripheral blood cells and early detection of breast cancer in asymptomatic patients - Praveen Sharma

  
  

• Predictive factors linked to the presence of BRCA1 and BRCA2 mutations - Carla Warlam-Rodenhuis

  
  

• Stress and breast cancer - Naja Rod Nielsen

  
  

• The impact of adjuvant taxanes on menstrual function in young patients with breast carcinoma - Monica Fornier

  
  

• Trastuzumab combined with docetaxel as first-line treatment in patients with HER2-positive metastatic breast cancer - Michel Marty

  
  

• Relationship between obesity status and chemotherapy dose reductions as a possible explanation for the poorer outcome in heavy women with breast cancer - Jennifer Griggs

  
  

• Axillary dissection in older patients with breast cancer - Gabriele Martelli

  
  

• Ki67 is a very useful marker of tumor aggressiveness among patients with early invasive breast cancer - Annamaria Molino

  
  

• Morbidity after sentinel lymph node biopsy in early breast cancer - Anand David Purushotham

  
  

• Full thickness chest wall resection with immediate reconstruction in patients with local solitary recurrence after mastectomy for breast malignancy - Wojciech Wysocki

  
  

• Serum HER2 may constitute a useful method of monitoring patients receiving trastuzumab-based therapy - Monica Fornier

  
  

• Delayed Nipple Sparing Subcutaneous Mastectomy - Beniamino Palmieri

  
  

• Menopause, hormone therapy and breast cancer risk - Carlo La Vecchia

  
  

Owner and Editor-in-Chief Gianpaolo Andreoletti, Oncologist and Science Journalist P.IVA. 01823870165

PRIVACY AND LEGAL DISCLAIMER